Sunrest Lifescience Ltd
₹ 54.0
0.00%
22 Nov
- close price
About
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]
Key Points
- Market Cap ₹ 23.2 Cr.
- Current Price ₹ 54.0
- High / Low ₹ 79.0 / 49.0
- Stock P/E 101
- Book Value ₹ 34.4
- Dividend Yield 0.00 %
- ROCE 15.4 %
- ROE 7.40 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 51.5%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
10.64 | 15.79 | 24.60 | 24.04 | 29.48 | |
10.49 | 15.51 | 23.49 | 21.14 | 28.57 | |
Operating Profit | 0.15 | 0.28 | 1.11 | 2.90 | 0.91 |
OPM % | 1.41% | 1.77% | 4.51% | 12.06% | 3.09% |
0.00 | 0.00 | 0.02 | 0.03 | 0.00 | |
Interest | 0.00 | 0.01 | 0.02 | 0.06 | 0.22 |
Depreciation | 0.02 | 0.04 | 0.06 | 0.13 | 0.10 |
Profit before tax | 0.13 | 0.23 | 1.05 | 2.74 | 0.59 |
Tax % | 76.92% | 21.74% | 25.71% | 25.55% | 61.02% |
0.04 | 0.17 | 0.78 | 2.04 | 0.23 | |
EPS in Rs | 40.00 | 170.00 | 780.00 | 6.80 | 0.54 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 23% |
TTM: | 23% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 11% |
TTM: | -89% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -28% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 52% |
Last Year: | 7% |
Balance Sheet
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2024 | |
---|---|---|---|---|---|
Equity Capital | 0.01 | 0.01 | 0.01 | 3.00 | 4.29 |
Reserves | 0.12 | 0.28 | 1.06 | 0.11 | 10.48 |
2.27 | 2.31 | 3.24 | 2.14 | 5.45 | |
3.85 | 6.88 | 8.71 | 11.47 | 6.93 | |
Total Liabilities | 6.25 | 9.48 | 13.02 | 16.72 | 27.15 |
0.03 | 0.15 | 0.47 | 0.35 | 0.04 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 |
6.22 | 9.33 | 12.55 | 16.35 | 27.11 | |
Total Assets | 6.25 | 9.48 | 13.02 | 16.72 | 27.15 |
Cash Flows
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
-0.90 | 0.15 | -0.44 | 1.15 | -14.80 | |
-0.01 | -0.16 | -0.36 | -0.03 | -0.01 | |
1.11 | 0.04 | 0.90 | -1.15 | 14.64 | |
Net Cash Flow | 0.20 | 0.03 | 0.11 | -0.03 | -0.16 |
Ratios
Figures in Rs. Crores
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 184.22 | 171.06 | 138.73 | 164.89 | |
Inventory Days | 23.71 | 48.88 | 48.05 | 96.71 | |
Days Payable | 174.84 | 206.14 | 165.68 | 211.59 | |
Cash Conversion Cycle | 33.08 | 13.80 | 21.10 | 50.01 | |
Working Capital Days | 69.64 | 48.08 | 49.56 | 66.81 | |
ROCE % | 9.60% | 30.39% | 58.58% |
Documents
Announcements
-
Outcome of Board Meeting
14 November 2024 - Sunrest Lifescience Limited has informed regarding Board meeting held on November 14, 2024.
-
Financial Result Updates
14 November 2024 - Sunrest Lifescience Limited has submitted to the Exchange, the financial results for the period ended September 30, 2024.
-
Board Meeting Intimation
6 November 2024 - SUNREST LIFESCIENCE LIMITED has informed about Board Meeting to be held on 14-Nov-2024 to inter-alia consider and approve the Unaudited Financial results of the Company …
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
21 October 2024 - Sunrest Lifescience Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 October 2024 - Sunrest Lifescience Limited has informed about Certificate under SEBI (Depositories and Participants) Regulations, 2018
Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste